IP Verse

Bayer Gmbhbayer Pharma Aktiengesellschaftbayer Animal Health competitive analysis

Latest oppositions filed by Bayer Gmbhbayer Pharma Aktiengesellschaftbayer Animal Health

Explore patent oppositions filed by Bayer Gmbhbayer Pharma Aktiengesellschaftbayer Animal Health against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
EP2462158
Method To Improve Virus Removal In Protein PurificationF HOFFMANN LA ROCHEOct 10, 2018
EP2591114
Immunisation Of Large Mammals With Low Doses Of RnaGLAXOSMITHKLINE BIOLOGICALS SAMar 7, 2017
EP2322153
Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGEN, INC.Jul 8, 2015
EP2322155
Use Of Hif Alpha Stabilizers For Enhancing ErythropoiesisFIBROGEN, INC.May 13, 2015

Latest PTAB cases involving Bayer Gmbhbayer Pharma Aktiengesellschaftbayer Animal Health

Discover the latest PTAB cases involving Bayer Gmbhbayer Pharma Aktiengesellschaftbayer Animal Health, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bayer Gmbhbayer Pharma Aktiengesellschaftbayer Animal Health with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BAYER GMBHBAYER PHARMA AKTIENGESELLSCHAFTBAYER ANIMAL HEALTH4 - - -
F HOFFMANN LA ROCHE34231 - -
FIBROGEN, INC.320 - 6
GENENTECH - 123 - 66